Nexstim Oyj

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FI4000506811
EUR
8.98
0.08 (0.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 65 Million ()

stock-summary
P/E

64.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.35

stock-summary
Return on Equity

13.71%

stock-summary
Price to Book

15.52

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.72%
0%
8.72%
6 Months
32.06%
0%
32.06%
1 Year
99.56%
0%
99.56%
2 Years
142.05%
0%
142.05%
3 Years
96.07%
0%
96.07%
4 Years
101.71%
0%
101.71%
5 Years
186.74%
0%
186.74%

Nexstim Oyj for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
21.70%
EBIT Growth (5y)
17.00%
EBIT to Interest (avg)
-0.77
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.41
Sales to Capital Employed (avg)
1.03
Tax Ratio
0.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.39%
ROE (avg)
6.42%

Valuation key factors

Factor
Value
P/E Ratio
64
Industry P/E
Price to Book Value
15.25
EV to EBIT
65.22
EV to EBITDA
38.20
EV to Capital Employed
11.57
EV to Sales
5.95
PEG Ratio
0.40
Dividend Yield
NA
ROCE (Latest)
11.27%
ROE (Latest)
13.71%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Nexstim Oyj"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 20.83% vs -24.21% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.77% vs -200.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.70",
          "val2": "7.20",
          "chgp": "20.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-1.00",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.10",
          "chgp": "400.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-1.30",
          "chgp": "30.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-69.80%",
          "val2": "-166.20%",
          "chgp": "9.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
8.70
7.20
20.83%
Operating Profit (PBDIT) excl Other Income
-0.40
-1.00
60.00%
Interest
0.50
0.10
400.00%
Exceptional Items
0.00
-0.00
Consolidate Net Profit
-0.90
-1.30
30.77%
Operating Profit Margin (Excl OI)
-69.80%
-166.20%
9.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 20.83% vs -24.21% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 30.77% vs -200.00% in Dec 2023

stock-summaryCompany CV
About Nexstim Oyj stock-summary
stock-summary
Nexstim Oyj
Pharmaceuticals & Biotechnology
Nexstim Oyj is a Finland-based medical technology company. It is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.
Company Coordinates stock-summary
Company Details
Elimaenkatu 9 B , HELSINKI None : 00510
stock-summary
Tel: 358 9 272717044 20 37095700
stock-summary
Registrar Details